The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial
Abstract
In Brief Objective: Evaluation of the use of testosterone therapy for hypoactive sexual desire disorder (HSDD) after oophorectomy has mostly involved women treated with oral estrogen preparations. We investigated the efficacy and safety of a testosterone patch in surgically menopausal women receiving concurrent transdermal estrogen. Design: Women with HSDD after oophorectomy, for whom this was a concern, who were using transdermal estrogen, were recruited to a 24-week, randomized, double-blind, placebo-controlled trial in Europe and Australia. Patients were randomly allocated to placebo (n = 40) or testosterone 300 μg/day (n = 37) treatment. Primary endpoints were changes in sexual desire measured by the sexual desire domain of the Profile of Female Sexual Function and the frequency of satisfying sexual activity at 24 weeks. Results: Sixty-one women (79%) completed the trial. All subjects who received at least one application of study medication were included in analysis. The testosterone-treated group experienced a significantly greater change from baseline in the domain sexual desire score compared with placebo (change from baseline, 16.43 versus 5.98; P = 0.02). The domain scores for arousal, orgasm, decreased sexual concerns, responsiveness, and self-image as well as decreased distress were also significantly greater with testosterone therapy than placebo. The frequency of satisfactory sexual events increased but was not statistically different between treatment groups (P = 0.06) Adverse events occurred with similar frequency in both groups, and no serious risks of therapy were observed Conclusions: In this study, transdermal testosterone therapy via a skin patch improved sexual desire and other sexual function domains. It was well tolerated in these oophorectomized women with HSDD receiving concomitant transdermal estrogen. Published studies of testosterone therapy for surgically menopausal women have mostly involved concurrent oral estrogen therapy. In this trial, oophorectomized women with low sexual desire using transdermal estradiol therapy were treated with transdermal testosterone therapy or placebo. Testosterone therapy significantly improved sexual desire and other sexual function domains versus placebo and was well tolerated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among adult women, endogenous testosterone does not show significant correlations with sexual behavior (Roney and Simmons, 2013), but exogenous testosterone treatment in women has been found to increase sexual desire, sexual activity, and sexual self-image (Buster et al., 2005, Davis et al., 2006, Shifren et al., 2006).”
From Becoming a sexual being: The “elephant in the room” of adolescent brain development (2017) · cites this paper as Davis et al., 2006
Citations
Cites
Sexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119
Assessment of quality of life in clinical trials of cardiovascular therapies
WENGER, N. K., Mattson, M. E., Furberg, C. D., & Elinson, J. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80232-5 · Cited by 986
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954
(1984) · Medical Entomology and Zoology · Cited by 741
Sherwin, B. B., Gelfand, M. M., & Brender, W. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00004 · Cited by 547
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
Davis, S. R., McCloud, P., Strauss, B. J., & Burger, H. (1995) · Maturitas · doi:10.1016/0378-5122(94)00898-h · Cited by 534
Self-citationTestosterone patch for low sexual desire in surgically menopausal women: a randomized trial
Buster, J. E., Kingsberg, S. A., Aguirre, O., Brown, C., Breaux, J. G., Buch, A., Rodenberg, C. A., Wekselman, K., & Casson, P. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158103.27672.0d · Cited by 433
Self-citationRosen, R. C., Taylor, J. F., Leiblum, S. R., & Bachmann, G. A. (1993) · Journal of Sex & Marital Therapy · doi:10.1080/00926239308404902 · Cited by 395
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394 · cited 1×
“5 [31, 58] 29 42 [30, 69] 300 Kg/day 33 50 [40, 85] 29 42 [36, 63] 25 54 [41, 63] Total dihydrotestosterone [6-31 ng/dL] Placebo 31 8 [5, 12] 29 7 [5, 11] 25 9 [6, 14] 300 Kg/day 31 6 [4, 8] 27 19 [14, 27] 22 17.”
Cited by
Sorted by citations
Items 101–200 of 249
Review: Testosterone therapy for reduced libido in women
Basson, R. J. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810379588 · Cited by 29
Disorders in sexual desire and sexual arousal in women, a 2010 state of the art
Both, S., Laan, E. T. M., & Schultz, W. C. M. W. (2010) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/0167482x.2010.528628 · Cited by 29
Designing drugs for the treatment of female sexual dysfunction
Brown, A. D., Blagg, J., & Reynolds, D. S. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.007 · Cited by 29
Walther, A., Tsao, C., Pande, R., Kirschbaum, C., Field, E., & Berkman, L. F. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104382 · Cited by 27
An update on the pharmacological management of female sexual dysfunction
Fooladi, E., & Davis, S. R. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.725046 · Cited by 26
Self-citationConsensus statement for non-hormonal-based treatments for menopausal symptoms
Woyka, J. (2017) · Post Reproductive Health · doi:10.1177/2053369117711646 · Cited by 26
Management strategies in SSRI-associated sexual dysfunction in women at midlife
Fooladi, E., Bell, R. J., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.658461 · Cited by 26
Self-citationBlümel, J. E., del Pino, M. A., Aprikian, D., Vallejo, S., Sarrá, S., & Castelo‐Branco, C. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802454919 · Cited by 26
Tucker, P. E., & Cohen, P. A. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000943 · Cited by 24
Prescribing testosterone and DHEA: The role of androgens in women
Smith, T. L., & Batur, P. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20030 · Cited by 25
Maserejian, N. N., Parish, S. J., Shifren, J. L., Huang, L., Gerstenberger, E. P., & Rosen, R. C. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.2152 · Cited by 26
Pharmacotherapy for women's sexual dysfunction
Basson, R. J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903004184 · Cited by 23
The Safety of Postmenopausal Testosterone Therapy
Maclaran, K., & Panay, N. (2012) · Women s Health · doi:10.2217/whe.12.11 · Cited by 23
Female Sexual Desire--Beyond Testosterone
Ganz, P. A., & Greendale, G. A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk175 · Cited by 25
Categories of Female Sexual Dysfunction
Amato, P. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2006.10.003 · Cited by 23
Fu, L., Liu, Y., Wang, J., Sun, Y., Zhang, L., Wu, T., Li, Y., Wang, B., Huang, S.-T., Bu, H., et al. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000497 · Cited by 22
Davey, D. A. (2012) · Women s Health · doi:10.2217/whe.12.27 · Cited by 22
Bennink, H. J. T. C., Zimmerman, Y., Laan, E. T. M., Termeer, H. M. M., Appels, N., Albert, A., Fauser, B. C. J. M., Thijssen, J. H. H., & van Lunsen, R. H. W. (2016) · Contraception · doi:10.1016/j.contraception.2016.06.022 · Cited by 21
Flibanserin for hypoactive sexual desire disorder: place in therapy
Gelman, F., & Atrio, J. (2017) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622316679933 · Cited by 21
Use of Testosterone in Postmenopausal Women
Davis, S. R. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.11.002 · Cited by 20
Self-citationTestosterone and the heart: friend or foe?
Davis, S. R. (2023) · Climacteric · doi:10.1080/13697137.2023.2250252 · Cited by 20
Self-citationAndrogens and breast cancer risk
Kenemans, P., & van der Mooren, M. J. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.651925 · Cited by 20
Challenges in the Gynecologic Care of Premenopausal Women With Breast Cancer
Bakkum-Gamez, J. N., Laughlin, S. K., Jensen, J. R., Akogyeram, C. O., & Pruthi, S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0794 · Cited by 20
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00020-1 · Cited by 20
The antidepressant effect of testosterone: An effect of neuroplasticity?
Walther, A., Wasielewska, J. M., & Leiter, O. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.05.004 · Cited by 20
Assessment of premature menopause on the sexual function and quality of life in women
Javadpour, S., Sharifi, N., Mosallanezhad, Z., Rasekhjahromi, A., & Jamali, S. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1871894 · Cited by 22
Krysiak, R. G., Drosdzol-Cop, A. B., Skrzypulec‐Plinta, V., & Okopień, B. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.11.002 · Cited by 20
Vieillissement sexuel : mythes et réalités biologiques
Bondil, P. (2008) · Sexologies · doi:10.1016/j.sexol.2008.06.001 · Cited by 19
Everhov, A. H., Rådestad, A. F., Nyberg, T., Smedby, K. E. E., Bergmark, K. H., & Hirschberg, A. L. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.022 · Cited by 19
Anderson, R. C., & Moffatt, C. E. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.01.001 · Cited by 19
‘Off-label’ drug use in sexual medicine treatment
Fallon, B. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901610 · Cited by 19
Casals, G., Ferrer, R., Urgell, E., Escobar-Morreale, H. F., Argente, J., Sesmilo, G., & Biagetti, B. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0020 · Cited by 20
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
Molkara, T., Akhlaghi, F., Ramezani, M. A., Salari, R., Vakili, V., Kamalinejad, M., Bordbar, M. R. F., Ghorbani, A., & Motavasselian, M. (2018) · Electronic physician · doi:10.19082/6577 · Cited by 17
Androgen therapy in women: What we think we know
Drillich, A., & Davis, S. R. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.02.005 · Cited by 17
Self-citationTestosterone Supplementation for Hypoactive Sexual Desire Disorder in Women
Woodis, C. B., McLendon, A. N., & Muzyk, A. J. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1004 · Cited by 17
Javadivala, Z., Khoei, E. M., Jafarabadi, M. A., Allahverdipour, H., Mirghafourvand, M., Nadrian, H., & Kouzekanani, K. (2018) · Sexual & Relationship Therapy · doi:10.1080/14681994.2018.1446515 · Cited by 17
Effect of Premature Menopause on Sexuality
Graziottin, A. (2007) · Women s Health · doi:10.2217/17455057.3.4.455 · Cited by 18
Testosterone use in postmenopausal women
Martínez, A., & Davis, S. R. (2020) · Climacteric · doi:10.1080/13697137.2020.1796961 · Cited by 35
Self-citationThe Safety of Testosterone Therapy in Women
Al-Imari, L., & Wolfman, W. (2012) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35385-3 · Cited by 18
Sexual arousal and response — the psychosomatic circle
Bancroft, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-05161-6.00004-5 · Cited by 16
Pharmacological Therapy for Female Sexual Dysfunction
Davis, S. R., & Nijland, E. A. (2008) · Drugs · doi:10.2165/00003495-200868030-00001 · Cited by 16
Self-citationAssessment & management of sexual problems in women
Wylie, K. R. (2007) · Journal of the Royal Society of Medicine · doi:10.1177/0141076807100012011 · Cited by 17
Care of Women in Menopause: Sexual Function, Dysfunction and Therapeutic Modalities
Mattar, C. N. Z., Chong, Y. S., Su, L., Agarwal, A. A., Wong, P., & Choolani, M. A. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n3p215 · Cited by 16
Renke, G., & Tostes, F. (2023) · Pharmaceuticals · doi:10.3390/ph16040619 · Cited by 13
Panjari, M., Bell, R. J., Adams, J., Morrow, C., Papalia, M.-A., Astbury, J., & Davis, S. R. (2008) · Journal of Women s Health · doi:10.1089/jwh.2007.0732 · Cited by 12
Self-citationManagement of hypoactive sexual desire disorder in transgender women: a guide for clinicians
Cocchetti, C., Ristori, J., Mazzoli, F., Vignozzi, L., Maggi, M., & Fisher, A. D. (2021) · International Journal of Impotence Research · doi:10.1038/s41443-021-00409-8 · Cited by 13
Testosterone for women: certainties and uncertainties
Davis, S. R. (2022) · Climacteric · doi:10.1080/13697137.2022.2146492 · Cited by 11
Self-citationDepressive symptoms are not associated with long-term integrated testosterone concentrations in hair
Walther, A., Wehrli, S., Kische, H., Penz, M., Wekenborg, M., Gao, W., Rothe, N., Beesdo-Baum, K., & Kirschbaum, C. (2020) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1795253 · Cited by 8
Zeinalzadeh, S., Akbarzadeh, M., Mohagheghzadeh, A., Faridi, P., & Sayadi, M. (2015) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587215595777 · Cited by 10
Attard, C. C., Cameron‐Pimblett, A., Puri, D., Rosa, C. L., Talaulikar, V. S., Davies, M. C., Learner, H. I., Liao, L., & Conway, G. S. (2020) · Clinical Endocrinology · doi:10.1111/cen.14271 · Cited by 10
The behavioral correlates of testosterone
Bancroft, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.006 · Cited by 10
Female Sexual Dysfunction: Is It a Treatable Disease?
Houman, J., Feng, T., EILBER, K. S., & Anger, J. T. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0583-5 · Cited by 9
van Winden, L. J., Vermeulen, R. F. M., van der Noort, V., Gaarenstroom, K. N., Kenter, G. G., Zanten, M. M. A. B.-V., Korse, C. M., van Beurden, M., & van Rossum, H. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac069 · Cited by 8
Drugs for the treatment of menopausal symptoms
Davis, S. R., & Jane, F. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003742962 · Cited by 10
Self-citationRole of androgens in modulating male and female sexual function
Traish, A. M. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.052 · Cited by 9
Women's expectations and experiences of hormone treatment for sexual dysfunction
Fooladi, E., Bell, R. J., Whittaker, A. M., & Davis, S. R. (2014) · Climacteric · doi:10.3109/13697137.2014.926322 · Cited by 9
Self-citationSexual dysfunction in women: Can we talk about it?
Faubion, S. S., & Parish, S. J. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84a.16021 · Cited by 11
The Bio-Psycho-Social Dimension in Women's Sexual Desire: 'Argumentum ad novitatem'.
Roslan, N., Jaafar, N. N., Sidi, H., Baharudin, N., Kumar, J., Das, S., & Hussain, N. H. N. (2018) · Current Drug Targets · doi:10.2174/1389450118666170622090337 · Cited by 9
Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
Johansen, N., Liavaag, A. H., Mørkrid, L., & Michelsen, T. M. (2018) · Sexual Medicine · doi:10.1016/j.esxm.2018.02.002 · Cited by 9
Basson, R. J. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.12.001 · Cited by 9
de Faro, L. F. T., & Russo, J. (2017) · Horizontes Antropológicos · doi:10.1590/s0104-71832017000100003 · Cited by 10
Understanding female sexual function
Davis, S. R. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31819c67a7 · Cited by 9
Self-citationPastoor, H., Both, S., Timman, R., Laan, E. T. M., & Laven, J. S. E. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.07.002 · Cited by 10
Barghamadi, S., Alimoradi, Z., Oleson, T., & Bahrami, N. (2020) · Trials · doi:10.1186/s13063-020-04663-x · Cited by 8
Risks of Testosterone for Postmenopausal Women
Pinkerton, J. V., Blackman, I., Conner, E. A., & Kaunitz, A. M. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.007 · Cited by 27
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Waldman, T., SHUFELT, C. L., & Braunstein, G. D. (2012) · Clinical Investigation · doi:10.4155/cli.12.18 · Cited by 8
Should women receive androgen replacement therapy, and if so, how?
Davis, S. R. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03670.x · Cited by 8
Self-citationPharmacologic therapy for female sexual dysfunction
Bradway, C. K., & Boullata, J. I. (2013) · The Nurse Practitioner · doi:10.1097/01.npr.0000440641.32261.7c · Cited by 8
Sexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause
Rech, C. M. Z., Clapauch, R., & Bouskela, E. (2019) · Journal of Women s Health · doi:10.1089/jwh.2017.6905 · Cited by 8
Should testosterone be added to estrogen-progestin therapy for breast protection?
Burger, H. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31802cdddd · Cited by 8
Androgens in postmenopausal women
Vigneswaran, K., & Hamoda, H. (2022) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12836 · Cited by 8
The Impact of Testosterone Therapy on Cardiovascular Risk Among Postmenopausal Women
Britton, R. C., & Beamish, N. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad132 · Cited by 7
Cooper, A. R., Covington, S. N., & Nelson, L. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-864-5_5 · Cited by 7
Musculoskeletal Health in Premature Ovarian Insufficiency. Part Two: Bone
Samad, N., Nguyen, H. H., Ebeling, P. R., & Milat, F. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1722849 · Cited by 7
Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism
Zang, H., & Davis, S. R. (2008) · Drugs · doi:10.2165/00003495-200868150-00001 · Cited by 7
Self-citationKulak, J., Urbanetz, A. A., Kulak, C. A. M., Borba, V. Z. C., & Boguszewski, C. L. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800019 · Cited by 7
Hypoactive Sexual Desire Disorder in Premenopausal Women: Case Studies
Miner, M. M., D, R. S. M., & Buster, J. E. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2522 · Cited by 6
Diagnosis and Treatment of Hypoactive Sexual Desire Disorder
Amato, P., & Buster, J. E. (2009) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181bf48c9 · Cited by 6
Götte, M., Kalkhake, K., Ploeger, S., Kiesel, L., & Stute, P. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.09.007 · Cited by 6
Sexual dysfunction service provision in UK genitourinary medicine clinics in 2007
Green, P., & Goldmeier, D. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2007.007153 · Cited by 6
Understanding Women's Sexual Health: A Case-Based Approach
Marnach, M. L., & Casey, P. M. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.12.1382 · Cited by 6
Osborne, V., Layton, D., & Shakir, S. (2014) · Post Reproductive Health · doi:10.1177/2053369114535762 · Cited by 5
Androgen replacement therapy in women
Lebbe, M., Hughes, D., Reisch, N., & Arlt, W. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.45 · Cited by 6
Impact of Hormones on Female Sexual Function and Dysfunction
Sandhu, K. S., Melman, A., & Mikhail, M. S. (2011) · Urogynecology · doi:10.1097/spv.0b013e318204491f · Cited by 5
Botelho, M. A., de Queiróz, D. B., Carvalho, C. F., Freitas, A., Barros, G., Gouvea, J., Patrus, L., Bannet, M., do Rêgo, A. C. M., Araújo-Filho, I., et al. (2015) · Medical Express · doi:10.5935/medicalexpress.2015.05.03 · Cited by 6
Cipriani, S., Maseroli, E., & Vignozzi, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_8 · Cited by 5
Drug Utilization of Intrinsa® (Testosterone Patch) in England
Osborne, V., Hazell, L., Layton, D., & Shakir, S. (2010) · Drug Safety · doi:10.2165/11533720-000000000-00000 · Cited by 5
Non-estrogen-based treatments for menopausal symptoms
Pitkin, J., REES, M. C. P., Gray, S., Lumsden, M. A., Marsden, J., Stevenson, J. C., & Williamson, J. (2008) · Menopause international · doi:10.1258/mi.2008.008009 · Cited by 5
Self-citationTreating Women's Sexual Desire and Arousal Problems
Both, S., Schultz, W. C. M. W., & Laan, E. T. M. (2017) · Wiley eBooks · doi:10.1002/9781118510384.ch2 · Cited by 5
Clinical management of androgen excess and defect in women
Rosato, E., Sciarra, F., Minnetti, M., Degjoni, A., & Venneri, M. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2279537 · Cited by 4
Santoro, N., & Wierman, M. E. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000658 · Cited by 4
Hypoactive sexual desire disorder
RYMER, J. M., Wylie, K. R., Barnes, T., Mander, A. M., Buckler, H. M., & Dean, J. P. (2010) · The Obstetrician & Gynaecologist · doi:10.1576/toag.12.4.237.27615 · Cited by 4
Confronting the Challenges of Postmenopausal Urogenital Health
Farage, M. A., Miller, K. W., & Ledger, W. J. (2010) · Aging Health · doi:10.2217/ahe.10.44 · Cited by 4
Sexual health consequences of premature ovarian failure
Davis, S. R. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318150d833 · Cited by 4
Self-citationViana, D. P. D. C., Câmara, L. C., & Alto, L. D. S. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1789504 · Cited by 5
Chapitre 8 : Sexualité et ménopause
Author, N. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.02.147 · Cited by 3
Clapauch, R., Weiss, R. V., & Rech, C. M. Z. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_17 · Cited by 4
Management of Hypoactive Sexual Desire Disorder (HSDD)
Krapf, J. M., Buster, J. E., & Goldstein, A. T. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3100-2_21 · Cited by 3
Consensus statement for non-estrogen-based treatments for menopausal symptoms
Woyka, J., & Tanna, N. K. (2014) · Post Reproductive Health · doi:10.1177/2053369114536103 · Cited by 3
Metadata
- Authors
- Davis, S. R., van der Mooren, M. J., van Lunsen, R. H. W., Lopes, P., Ribot, J., Rees, M., Moufarege, A., Rodenberg, C., Buch, A., & Purdie, D. W.
- Affiliations
- Jean Hailes (AU)
- Hôpital Rangueil (FR)
- John Radcliffe Hospital (GB)
- Procter & Gamble (United Kingdom) (GB)
- Procter & Gamble (United States) (US)
- Corresponding author
- Davis, Susan R.
- ORCID
- Davis, Susan R.
- Venue
- Menopause
- Published
- 2006-05
- Volume
- 13
- Issue
- 3
- Pages
- 387-396
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W2799667742
- Cited by
- 250
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 11 · 2019: 7 · 2018: 13 · 2017: 13 · 2016: 15 · 2015: 7 · 2014: 11 · 2013: 8 · 2012: 18
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Menopause The Journal of The North American Menopause Society (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, hypoactive sexual desire disorder, oophorectomy, transdermal estradiol, sexual desire, female sexual function, treatment safety
- MeSH terms
- Administration, Cutaneous, Adult, Aged, Double-Blind Method, Estradiol, Female, Humans, Libido, Menopause, Premature, Middle Aged, Ovariectomy, Sexual Dysfunction, Physiological, Testosterone, Treatment Outcome, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review